Department of Otorhinolaryngology, Head & Neck Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, China.
Chin Med J (Engl). 2012 May;125(9):1603-7.
Interleukin-l7 (IL-17), which exerts strong pro-inflammatory effects, has emerged as an important mediator in inflammation-associated cancer. The aim of this study was to clarify the relationship between IL-17 and tumor associated macrophages (TAMs), and the correlation of the microvessel density in the development of laryngeal squamous cell carcinoma (LSCC).
Histopathological observations and immunohistochemistry staining for IL-17, CD68, and CD34 were performed on 72 specimens (32 cases of LSCC, 20 cases of adjacent tissues of carcinoma as controls, and 20 cases of chronic hypertrophic laryngitis). Double immunohistochemical staining was done to determine which cells expressed IL-17. Real-time quantitative PCR determined the mRNA expression of IL-17. ELISA was used to detect the expression of the serum level of IL-17 in the three groups.
The inflammation response had increased in LSCC. Overexpression of IL-17 and CD68 protein were seen in LSCC (P < 0.01). The expression of IL-17 was different between well and poorly differentiated LSCC (P < 0.01). The IL-17 expressing cells were mainly located in macrophages (CD68(+)/IL17(+)) as demonstrated by double immunohistochemical staining. IL-17 expression significantly correlated with high microvessel density (CD34(+)) in LSCC (P < 0.05). Relatively higher mRNA expression levels of IL-17 were seen in LSCC compared to the controls (P < 0.05). The serum expression of IL-17 was similar among the three groups (P > 0.05).
IL-17 was expressed by TAMs, and IL-17 may significantly correlate to the differentiation and angiogenesis in the development of LSCC.
白细胞介素-17(IL-17)具有很强的促炎作用,已成为炎症相关癌症的重要介质。本研究旨在阐明 IL-17 与肿瘤相关巨噬细胞(TAMs)之间的关系,以及微血管密度与喉鳞状细胞癌(LSCC)发展之间的相关性。
对 72 例标本(32 例 LSCC、20 例癌旁组织对照和 20 例慢性肥厚性喉炎)进行组织病理学观察和 IL-17、CD68 和 CD34 的免疫组织化学染色。进行双免疫组化染色以确定表达 IL-17 的细胞。实时定量 PCR 测定 IL-17 的 mRNA 表达。ELISA 用于检测三组血清中 IL-17 的表达水平。
LSCC 炎症反应增强。LSCC 中观察到 IL-17 和 CD68 蛋白过表达(P < 0.01)。IL-17 的表达在 LSCC 的高分化和低分化之间存在差异(P < 0.01)。双免疫组化染色显示,IL-17 表达细胞主要位于巨噬细胞(CD68(+)/IL17(+))中。IL-17 表达与 LSCC 中的高微血管密度(CD34(+))显著相关(P < 0.05)。与对照组相比,LSCC 中 IL-17 的相对 mRNA 表达水平较高(P < 0.05)。三组之间血清 IL-17 的表达无差异(P > 0.05)。
TAMs 表达 IL-17,IL-17 可能与 LSCC 的分化和血管生成密切相关。